Treatment of Prisoners With Attention Deficit Hyperactive Disorder in Trondheim Prison

This study has been completed.
Sponsor:
Information provided by:
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00356070
First received: July 24, 2006
Last updated: August 9, 2011
Last verified: July 2006
  Purpose

The treatment of ADHD in jail will help the prisoners in their rehabilitation process


Condition Intervention Phase
Attention Deficit Hyperactivity Disorder
Drug: Strattera
Phase 4

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Treatment of Prisoners With Attention Deficit Hyperactive Disorder in Trondheim Prison

Resource links provided by NLM:


Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:
  • The symptoms of Attention Deficit Hyperactive Disorders and the prisoners use of the prisons rehabilitation services before and after treatment will be measured

Estimated Enrollment: 40
Study Start Date: January 2006
Estimated Study Completion Date: December 2006
Detailed Description:

Prisoners with ADHD will be offered treatment with Stratera, and we wanted to study their use of the prisons rehabilitation offers as school, programs and work training before and after treatment with Stratera.

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

All prisoners that fullfill the diagnostic criterias for ADHD -

Exclusion Criteria:

All other prisoners -

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00356070

Locations
Norway
St. Olavs Hospital. Departement for forensic psyciatry, Brøset.
Trondheim, Norway, 7040
St.Olavs University Hospital, Departement for forensic psychiatry, Brøset
Trondheim, Norway, 7040
Sponsors and Collaborators
Norwegian University of Science and Technology
Investigators
Principal Investigator: Jim Aa Nøttestad, Dr. Philos St. Olavs Hospital, Departement of forensic psychiatry, Brøset
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00356070     History of Changes
Other Study ID Numbers: AH 4.2005.147
Study First Received: July 24, 2006
Last Updated: August 9, 2011
Health Authority: Norway: Norwegian Social Science Data Services

Keywords provided by Norwegian University of Science and Technology:
Attention Deficit Hyperactivity Disorder, treatment,
Strattera,
rehabilitation

Additional relevant MeSH terms:
Disease
Hyperkinesis
Attention Deficit Disorder with Hyperactivity
Pathologic Processes
Dyskinesias
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Attention Deficit and Disruptive Behavior Disorders
Mental Disorders Diagnosed in Childhood
Mental Disorders

ClinicalTrials.gov processed this record on September 18, 2014